Evaluating the “Pro” of Probiotics: No Benefits of Lactobacillus therapy for Pediatric Acute Gastroenteritis

While the verdict is still out on the benefits of probiotics, these supplements command a multibillion-dollar global market. Numerous clinical trials have aimed to determine the usefulness of probiotics, however, many have been hampered by limitations such as insufficient sample size. In this study, Freedman et al. investigate the efficacy of probiotics in the treatment of viral-induced pediatric acute gastroenteritis.

Continue ReadingEvaluating the “Pro” of Probiotics: No Benefits of Lactobacillus therapy for Pediatric Acute Gastroenteritis